Ally Bridge Group (NY) LLC
Follow13F filer, CIK 1822947, NEW YORK, NY
Ally Bridge Group (NY) LLC reported $76,049,458 across 18 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 95.18% of the portfolio.
Accepted , ingested 13F-HR 0001193125-26-463652
- Period
- 2026-09-30
- Reported value
- $76M
- Holdings
- 18
- Top 10 weight
- 95.18%
- New
- 6
- Sold out
- 13
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AMLXnew | +182,000 | $5.3M |
| STTKnew | +625,190 | $4.26M |
| OBXnew | +302,449 | $4.15M |
| EWTXadded | +102,130 | $4.15M |
| VOGXnew | +32,701 | $745K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TRAXexited | -284,287 | -$5.72M |
| AXSMexited | -16,493 | -$4.04M |
| WHWKexited | -817,939 | -$3.75M |
| CLYMexited | -249,172 | -$3.25M |
| KURAexited | -290,000 | -$3.18M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-463652, largest first. % of portfolio is the value over $43,411,958, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| EWTXEDGEWISE THERAPEUTICS INC | 185,430 | $7.53M | 17.34% | +102,130 | Timeline | ||
| PMNPROMIS NEUROSCIENCES INC | 620,319 | $6.73M | 15.5% | 0 | Timeline | ||
| NERVMINERVA NEUROSCIENCES INC | 1,655,500 | $5.55M | 12.78% | -520,302 | Timeline | ||
| AMLXAMYLYX PHARMACEUTICALS INC | 182,000 | $5.3M | 12.2% | new | Timeline | ||
| STTKSHATTUCK LABS INC | 625,190 | $4.26M | 9.82% | new | Timeline | ||
| OBXOBSIDIAN THERAPEUTICS INC | 302,449 | $4.15M | 9.57% | new | Timeline | ||
| ANTXAN2 THERAPEUTICS INC | 526,315 | $2.8M | 6.45% | 0 | Timeline | ||
| EPRXEUPRAXIA PHARMACEUTICALS INC | 231,122 | $2.1M | 4.84% | -21,053 | Timeline | ||
| AVTXAVALO THERAPEUTICS INC | 134,429 | $2.06M | 4.75% | -15,571 | Timeline | ||
| IVAINVENTIVA SA | 227,250 | $839K | 1.93% | -407,550 | Timeline | ||
| VOGXVOGENX INC | 32,701 | $745K | 1.72% | new | Timeline | ||
| TRAWTRAWS PHARMA INC | 786,236 | $467K | 1.08% | 0 | Timeline | ||
| CATXPERSPECTIVE THERAPEUTICS INC | 163,634 | $450K | 1.04% | -580,324 | Timeline | ||
| ASMBASSEMBLY BIOSCIENCES INC | 18,298 | $430K | 0.99% | -121,702 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| TRAXFIRST TRACKS BIOTHERAPEUTICS | 284,287 | $5.72M | shares |
| AXSMAXSOME THERAPEUTICS INC. | 16,493 | $4.04M | shares |
| WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $3.75M | shares |
| CLYMCLIMB BIO INC | 249,172 | $3.25M | shares |
| KURAKURA ONCOLOGY INC | 290,000 | $3.18M | shares |
| CTMXCYTOMX THERAPEUTICS INC. | 775,000 | $2.91M | shares |
| PALIPALISADE BIO INC | 1,229,000 | $2.57M | shares |
| SLDBSOLID BIOSCIENCES INC | 255,959 | $2.56M | shares |
| URGNUROGEN PHARMA LTD | 69,183 | $2.55M | shares |
| IDYAIDEAYA BIOSCIENCES INC | 67,500 | $2.52M | shares |
| ALMSALUMIS INC | 76,459 | $2.15M | shares |
| OVIDOVID THERAPEUTICS INC | 624,561 | $1.68M | shares |
| IBIOIBIO INC | 390,147 | $683K | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-463652 | base | 2026-11-16 |